Literature DB >> 9393785

Progression of visceral leishmaniasis due to Leishmania infantum in BALB/c mice is markedly slowed by prior infection with Trichinella spiralis.

D Rousseau1, Y Le Fichoux, X Stien, I Suffia, B Ferrua, J Kubar.   

Abstract

We investigated in BALB/c mice the influence of the immunological environment created by the nematode Trichinella spiralis on the course of visceral leishmaniasis due to Leishmania infantum. On the day of Leishmania inoculation (day 0), mice, T. spiralis infected 7 days earlier, presented increased gamma interferon (IFN-gamma), interleukin-4 (IL-4), and IL-5 mRNA levels locally and systemically and increased the potential of spleen cells to synthesize IFN-gamma and IL-4 after activation in vitro. Eighteen days after Leishmania inoculation (day 18), corresponding to the acute phase of leishmaniasis, the hepatic amastigote burden in mice coinfected with L. infantum and T. spiralis (LT mice) was significantly lower (P < 0.001) than that in mice infected with L. infantum only (L mice). IFN-gamma and IL-4 mRNAs were overexpressed in livers of LT and L mice. On day 70, corresponding to the chronic phase, the splenic amastigote load was significantly lower (P = 0.004) in LT mice than it was in L mice. Splenic IFN-gamma transcripts were overexpressed in both L and LT mice. After Leishmania-specific in vitro stimulation, cytokine production was enhanced in both groups, but spleen cells from L mice produced significantly more IFN-gamma than did spleen cells from LT mice. Our data (i) generalize previous results indicating the lack of a clear-cut correlation between the outcome of murine visceral leishmaniasis and the type of cytokine pattern and (ii) demonstrate that in LT mice, leishmaniasis takes a markedly milder course than it does in L mice, providing information on the potential consequences of coinfection in a mammalian host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393785      PMCID: PMC175718          DOI: 10.1128/iai.65.12.4978-4983.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Early IL-4 production does not predict susceptibility to Leishmania major.

Authors:  P Scott; A Eaton; W C Gause; X di Zhou; B Hondowicz
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

2.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma.

Authors:  H W Murray; J J Stern; K Welte; B Y Rubin; S M Carriero; C F Nathan
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

4.  Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.

Authors:  K Zwingenberger; G Harms; C Pedrosa; S Omena; B Sandkamp; S Neifer
Journal:  Clin Immunol Immunopathol       Date:  1990-11

5.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

Authors:  P M Kaye; A J Curry; J M Blackwell
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

6.  Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.

Authors:  J J Stern; M J Oca; B Y Rubin; S L Anderson; H W Murray
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

7.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.

Authors:  M Belosevic; D S Finbloom; P H Van Der Meide; M V Slayter; C A Nacy
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

8.  Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease-promoting CD4+ cells are different from TH2 cells.

Authors:  H Moll; M Röllinghoff
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

9.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.

Authors:  D Vercelli; H H Jabara; B W Lee; N Woodland; R S Geha; D Y Leung
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  12 in total

1.  Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response.

Authors:  L R Schopf; J L Bliss; L M Lavigne; C L Chung; S F Wolf; J P Sypek
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis.

Authors:  R Khatonier; A M Khan; P Sarmah; G U Ahmed
Journal:  J Parasit Dis       Date:  2018-08-22

4.  Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

Authors:  Y Le Fichoux; D Rousseau; B Ferrua; S Ruette; A Lelièvre; D Grousson; J Kubar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

5.  Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.

Authors:  Edézio Ferreira Cunha-Júnior; Thiago Martino Martins; Marilene Marcuzzo Canto-Cavalheiro; Paulo Roberto Marques; Elyzabeth Avvad Portari; Marsen Garcia Pinto Coelho; Chaquip Daher Netto; Paulo Roberto Ribeiro Costa; Katia Costa de Carvalho Sabino; Eduardo Caio Torres-Santos
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  Coinfection with Clonorchis sinensis modulates murine host response against Trichinella spiralis infection.

Authors:  Ying Chen; Bo Huang; Shiguang Huang; Xinbing Yu; Yonglong Li; Wenjian Song; Yongxiang Li; Fangli Lu
Journal:  Parasitol Res       Date:  2013-07-12       Impact factor: 2.289

7.  In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection.

Authors:  D Rousseau; S Demartino; B Ferrua; J F Michiels; F Anjuère; K Fragaki; Y Le Fichoux; J Kubar
Journal:  BMC Microbiol       Date:  2001-08-17       Impact factor: 3.605

8.  Toxoplasma Co-infection Prevents Th2 Differentiation and Leads to a Helminth-Specific Th1 Response.

Authors:  Norus Ahmed; Timothy French; Sebastian Rausch; Anja Kühl; Katrin Hemminger; Ildiko R Dunay; Svenja Steinfelder; Susanne Hartmann
Journal:  Front Cell Infect Microbiol       Date:  2017-07-25       Impact factor: 5.293

9.  Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis.

Authors:  Rebecca C Furze; Tracy Hussell; Murray E Selkirk
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectants.

Authors:  Konstantina Fragaki; Bernard Ferrua; Baharia Mograbi; Julie Waldispühl; Joanna Kubar
Journal:  BMC Microbiol       Date:  2003-04-30       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.